Valuation check: RVTY's profit margin is 8.16%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Revvity (RVTY) currently reports a profit margin of 8.16% as of June 2026. That compares with 11.11% in the prior-year period — down 26.6% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Revvity's profit margin history and peer comparisons.
Revvity's profit margin decreased from 11.11% to 8.16% — a 26.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Revvity's profit margin of 8.16% is lower than the Healthcare sector average of 13.89%. That is roughly 41.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Revvity's current 8.16% should be judged against Healthcare norms (sector average: 13.89%) and against RVTY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 8.16%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Revvity, and consider following RVTY for alerts when major investors trade the stock.